Teva Tumbles as Price Deflation Catches Up With Imports August 3, 2017 Generic drug manufacturer Teva cut its full year revenue guidance by 5%, in part because of drug price deflation. Its stock price dropped 23% in response. Falling drug prices have been evident in U.S. import data for some time. Panjiva data shows average prices per kg fell 25% in the three mon... Read more →
Denmark
中文